The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
Aging leads to several geriatric conditions including osteoporosis (OP) and associated frailty syndrome. Treatments for these conditions are limited and none target fundamental drivers of pathology, and thus identifying strategies to delay progressive loss of tissue homeostasis and functional reserv...
Saved in:
| Main Authors: | William S. Hambright, Xiaodong Mu, Xueqin Gao, Ping Guo, Yohei Kawakami, John Mitchell, Michael Mullen, Anna-Laura Nelson, Chelsea Bahney, Haruki Nishimura, Justin Hellwinkel, Andrew Eck, Johnny Huard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.1155/2023/5572754 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NK‐Cell‐Derived Extracellular Vesicles Engineered to Carry Senolytics Eliminate Chemotherapy‐Induced Senescent Osteosarcoma Cells
by: Xianlin Yue, et al.
Published: (2025-07-01) -
Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs
by: Jinjun Li, et al.
Published: (2025-06-01) -
Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice
by: Bo Yang, et al.
Published: (2025-09-01) -
运用二代测序技术产前诊断ZMPSTE24基因突变
by: 麦明琴, et al.
Published: (2017-01-01) -
Sex, senescence, senolytics, and cognition
by: Thomas C. Foster, et al.
Published: (2025-03-01)